Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

NCT00275093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

130

Enrollment

NIH

Sponsor class

Conditions

Hepatic Complications
Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: temsirolimus
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)